Bactrim Dosing for Cellulitis
For adult patients with cellulitis requiring MRSA coverage, trimethoprim-sulfamethoxazole (Bactrim) should be dosed at 1-2 double-strength tablets (160mg/800mg) orally twice daily for 5 days, extending only if clinical improvement has not occurred within this timeframe. 1
When Bactrim is Appropriate vs. When It's Not
Bactrim should NOT be used as monotherapy for typical nonpurulent cellulitis because it lacks reliable activity against beta-hemolytic streptococci, which are the primary pathogens in most cellulitis cases. 1, 2
Specific Indications for Bactrim Use:
- Purulent cellulitis with drainage or exudate - requires MRSA coverage, and Bactrim must be combined with a beta-lactam (such as cephalexin) to cover streptococci 1, 2
- Penetrating trauma or injection drug use - mandates empirical MRSA coverage with combination therapy 1, 2
- Known MRSA colonization or documented MRSA infection elsewhere - requires MRSA-active antibiotics 2
- Systemic inflammatory response syndrome (SIRS) - indicates need for MRSA coverage 2
When Bactrim Should Be Avoided:
- Typical nonpurulent cellulitis without risk factors - beta-lactam monotherapy (cephalexin, dicloxacillin) is successful in 96% of cases 1, 2
- Never use Bactrim alone for cellulitis - always combine with a beta-lactam like cephalexin 500mg four times daily to ensure streptococcal coverage 1, 2
Dosing Algorithm
Standard Dosing:
- Adults: 1-2 double-strength tablets (160mg/800mg) twice daily 1
- Pediatric: 8-12 mg/kg/day (based on trimethoprim component) in 2 divided doses orally 1
Weight-Based Considerations:
Inadequate dosing (<5 mg TMP/kg/day) is independently associated with clinical failure (OR 2.01, p=0.032), so ensure adequate weight-based dosing for hospitalized patients. 3
Treatment Duration
- 5 days if clinical improvement occurs - this is the evidence-based standard duration 1, 2
- Extend beyond 5 days ONLY if symptoms have not improved within this initial timeframe 1, 2
- Do NOT reflexively extend to 7-10 days based on residual erythema alone, as some inflammation persists even after bacterial eradication 2
Critical Evidence on Combination Therapy
A landmark randomized controlled trial demonstrated that adding trimethoprim-sulfamethoxazole to cephalexin provided NO additional benefit for pure cellulitis without abscess, ulcer, or purulent drainage (85% cure rate with combination vs. 82% with cephalexin alone, p=0.66). 4 This confirms that MRSA coverage is unnecessary for typical nonpurulent cellulitis. 2
However, in MRSA-prevalent settings, antibiotics with MRSA activity (trimethoprim-sulfamethoxazole or clindamycin) demonstrated significantly higher success rates than cephalexin alone (91% vs 74%, p<0.001) when MRSA was subsequently culture-confirmed. 5
Alternative MRSA-Active Options
If Bactrim is contraindicated or not tolerated:
- Clindamycin 300-450mg orally three times daily - covers both streptococci and MRSA as monotherapy, avoiding need for combination therapy (use only if local MRSA resistance <10%) 1, 2
- Doxycycline 100mg twice daily PLUS a beta-lactam - alternative combination regimen, but contraindicated in children <8 years and pregnancy 1, 2
Common Pitfalls to Avoid
- Do not use Bactrim as monotherapy - streptococcal coverage will be inadequate, leading to treatment failure 1, 2
- Do not add MRSA coverage reflexively for typical cellulitis without specific risk factors - this represents overtreatment and increases antibiotic resistance 2
- Do not continue ineffective antibiotics beyond 48 hours - progression despite appropriate therapy indicates resistant organisms or deeper infection requiring reassessment 2
Severe Infections Requiring Hospitalization
For cellulitis with systemic toxicity, hypotension, or suspected necrotizing fasciitis, IV vancomycin 15-20 mg/kg every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5g every 6 hours is mandatory, not oral Bactrim. 2